Journals / The Journal of Pediatric Research / 2016 / Cilt: 3 - Sayı: 4

Evaluation of Incidence and Characteristics of Necrotizing Enterocolitis in Neonatal Intensive Care Unit

Yenidoğan Yoğun Bakım Ünitesinde Nekrotizan Enterokolit Sıklığı ve Özelliklerinin Değerlendirilmesi

Pages
196–202
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Mortality risk is higher in advanced stages of the disease requiring surgery, and especially small babies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The aim of this study was to evaluate the risk factors, characteristic features, clinical and laboratory findings and mortality rates of necrotizing enterocolitis (NEC) patients.Materials and Methods: Thirty seven patients diagnosed with NEC among the 488 cases followed up in our clinic between 2010-2011 were included into this study.Results: The incidence of NEC was found as 7.5% among the total patient population.
📊
Key Findings & Data:Mean gestational age and birth weight of NEC patients were 27.5±2.5 weeks and 1044±485 grams.
💡
Conclusion & Impact:Mortality risk is higher in advanced stages of the disease requiring surgery, and especially small babies.
🔬Design:Research Article
📍Scope:2010-2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: The aim of this study was to evaluate the risk factors, characteristic features, clinical and laboratory findings and mortality rates of necrotizing enterocolitis (NEC) patients.Materials and Methods: Thirty seven patients diagnosed with NEC among the 488 cases followed up in our clinic between 2010-2011 were included into this study.Results: The incidence of NEC was found as 7.5% among the total patient population. Mean gestational age and birth weight of NEC patients were 27.5±2.5 weeks and 1044±485 grams. Ninety percent of NEC patients were born under 1500 grams and 30 weeks. Twenty-four cases were classified as stage 1, and 13 cases were classified as stage 2-3. Stage 2-3 NEC was diagnosed in 9.8% of very low birth weight infants. The mean gestational age, birth weight, gender, delivery type, Apgar scores and the incidence of intrauterine growth restriction, diagnosis and/or treatment of patent ductus arteriosus, retinopathy of prematurity, respiratory distress syndrome, intracranial hemorrhage were similar between patients with different stages of NEC. Gastrointestinal perforation developed in six of the stage 2-3 cases. Platelet count and hematocrit levels were lower (p<0.01 and p=0.02); mortality rate was higher (p=0.02) in stage 2-3 patients when compared to stage 1 patients. Conclusion: NEC is more common in newborns with low birth weight and low gestational age. The severity of the illness is closely associated with laboratory abnormalities such as anemia, leucopenia, leukocytosis, thrombocytopenia and elevated C-reactive protein levels. Mortality risk is higher in advanced stages of the disease requiring surgery, and especially small babies.

Özet

Amaç: Bu çalışma nekrotizan enterokolit (NEK) tanısı ile izlenen olgularda hastalığın risk faktörleri, karakteristik özellikleri, klinik, laboratuvar bulguları ve mortalite oranının değerlendirilmesi amacıyla yapılmıştır.Gereç ve Yöntemler: Çalışmaya 2010-2011 yıllarında kliniğimizde izlenen 488 hasta yenidoğan içinde NEK tanısı alan 37 bebek dahil edilmiştir.Bulgular: NEK sıklığı tüm yatan hasta popülasyonunda %7,5 olarak bulundu. NEK olgularında ortalama gebelik yaşı, 27,5±2,5 hafta, ortalama doğum ağırlığı, 1044±485 gram idi ve NEK'li olguların %90'ı <1500 gr ve 30 hafta altında doğmuştu. Yirmi dört olgu evre 1, 13 olgu evre 2-3 olarak sınıflandırıldı. Çok düşük doğum ağırlıklı bebeklerde evre 2-3 NEK %9,8 sıklıkla görüldü. Bebeklerin ortalama gebelik haftası, doğum ağırlığı, cinsiyet, doğum şekli, Apgar skorları, patent duktus arteriozus varlığı ve tedavisi, intrauterin büyüme kısıtlılığı, prematüre retinopatisi, Respiratuvar distres sendromu, intrakraniyal kanama varlığı ile NEK evreleri arasında fark bulunmadı. Evre 2-3 olgularının altısında gastrointestinal perforasyon gelişti. Evre 2-3 NEK olguları evre 1 NEK olguları ile karşılaştırıldığında; trombosit ve hematokrit değerlerinin anlamlı olarak daha düşük (p<0,01 ve p=0,02), mortalitenin daha yüksek olduğu görüldü (p=0,02).Sonuç: NEK gelişen olgularda çok düşük doğum ağırlığı ve gebelik haftası olduğu ve anemi, lökopeni, lökositoz, trombositopeni ve C-reaktif protein yüksekliği gibi laboratuvar bulgularının hastalığın ciddiyeti ile ilişkili olduğu gözlendi. İleri evre, cerrahi gerektiren olgularda ve özellikle de küçük bebeklerde mortalite riski yüksektir.

🔖

Cite This Article

BİLGİN, B. S., TEREK, D., KÖROĞLU, Ö. A., YALAZ, M., AKISÜ, M., ÇELİK, A., ERGÜN, O., KÜLTÜRSAY, N. (2016). Evaluation of Incidence and Characteristics of Necrotizing Enterocolitis in Neonatal Intensive Care Unit. The Journal of Pediatric Research, Cilt: 3 - Sayı: 4, 196–202. https://ajindex.com/articles/362961

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med 2011;364:255-64.
  2. Lin PW, Nasr TR, Stoll BJ. Necrotizing enterocolitis: recent scientific advances in pathophysiology and prevention. Semin Perinatol 2008;32:70-82.
  3. Hsueh W, Caplan MS, Qu XW, Tan XD, De Plaen IG, Gonzalez-Crussi F. Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatr Dev Pathol 2003;6:6-23.
  4. Lim JC, Golden JM, Ford HR. Pathogenesis of neonatal necrotizing enterocolitis. Pediatr Surg Int 2015;31:509-18.
  5. Akisu M, Baka M, Huseyinov A, Kultursay N. The role of dietary supplementation with L-glutamine in inflammatory mediator release and intestinal injury in hypoxia/reoxygenation- induced experimental necrotizing enterocolitis. Ann Nutr Metab 2003;47:262-6.
  6. Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 1986;33:179-201.
  7. Erdeve O, Yurttutan S, Altug N, et al. Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2012;97:279-83. International Committee for the Classification of Retinopathy of P. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 2005;123:991-9.
  8. Papile LA, Munsick-Bruno G, Schaefer A. Relationship of cerebral intraventricular hemorrhage and early childhood neurologic handicaps. J Pediatr 1983;103:273-7.
  9. Stoll BJ, Hansen NI, Bell EF, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010;126:443-56.
  10. Fanaroff AA, Stoll BJ, Wright LL, et al. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 2007;196:147. Yee WH, Soraisham AS, Shah VS, et al. Incidence and timing of presentation of necrotizing enterocolitis in preterm infants. Pediatrics 2012;129:298-304.
  11. Özkan H, Çetinkaya M, Köksal N, Özboyacı E, Özboyacı A, Yapıcı Ş. Nekrotizan Enterokolitli Prematüre Bebeklerin Değerlendirilmesi. J Curr Pediatr 2010;8:56-62.
  12. March MI, Gupta M, Modest AM, et al. Maternal risk factors for neonatal necrotizing enterocolitis. J Matern Fetal Neonatal Med 2014:1-6.
  13. Miner CA, Fullmer S, Eggett DL, Christensen RD. Factors affecting the severity of necrotizing enterocolitis. J Matern Fetal Neonatal Med 2013;26:1715-9.
  14. Manogura AC, Turan O, Kush ML, et al. Predictors of necrotizing enterocolitis in preterm growth-restricted neonates. Am J Obst